Registration Dossier

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

In accordance with column 2 of REACH Annex X, as the substance is not mutagenic and as no hyperplasia and/or pre-neoplastic lesions were observed in the repeated dose studies, a carcinogenicity study is not necessary.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Mode of Action Analysis / Human Relevance Framework

No information available.

Additional information

Justification for classification or non-classification

Based on the negative results in the in vitro and in vivo genotoxicity studies, and the absence of hyperplasia and/or pre-neoplastic lesions in the available repeated dose studies, MIPA is considered to be non-carcinogenic. As a result the substance is not considered to be classified for carcinogenicity under Regulation (EC) No. 1272/2008.